In patients presenting as TTP, antibodies to ADAMTS13 were detected in all but three cases (in which ADAMTS13 antibody evaluation was not available), and ADAMTS13 activity was reported as <10% in all reported cases. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.